The ELISA human myeloperoxidase (MPO) test quantifies human MPO in serum, plasma, buffered solution or human cell culture medium. The dosage will recognize only natural and recombinant human MPO. Principle...
The ELISA human myeloperoxidase (MPO) test quantifies human MPO in serum, plasma, buffered solution or human cell culture medium. The dosage will recognize only natural and recombinant human MPO. The principle of the solid-phase L-ELISA sandwich method for human MPO (an immuno-enzymatic test) is designed to measure the amount of the target bound between a pair of matched antibodies. A target-specific antibody was pre-assembled in the wells of the supplied microplate. Samples, standards or controls are then added to these wells and bind to the immobilized antibody (capture). The sandwich is formed by adding the second antibody (detector), a substrate solution that reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this coloured product is directly proportional to the concentration of TP (p) present in the original sample. Rigorous validation Each batch manufactured from this ELISA kit is tested for quality for criteria such as sensitivity, specificity, accuracy and batch-to-batch consistency. See the product manual for more information on validation.
Myeloperoxidase (MPO) is a hemoprotein that is expressed in abundance in neutrophils and secreted during activation. Native myeloperoxidase is represented as a covalently bound tetrameric complex of two alpha glycosylated chains with a molecular weight range of 59 - 64 kDa and two nonglycosylated beta chains (MW -14 kDa) with a total MW -150 kDa and a theoretical pI of 9.2. Traditionally, myeloperoxidase was considered the primary target of anti-neutrophilic cytoplasmic antibodies (ANCA), serological markers of certain systemic vasculities such as periarteriitis nodosa, microscopic polyarteriitis, and pulmonary eosinophilic granulomatosis (Churg-Strauss syndrome). Low to moderate levels of auto-anti-myeloperoxidase antibodies are also reported in rheumatoid arthritis. Recently, myeloperoxidase has been shown to be involved in the initiation and progression of cardiovascular disease. Myeloperoxidase has powerful pro-inflammatory properties and can directly contribute to tissue damage. Myeloperoxidase is now considered one of the most promising cardiac markers. Myeloperoxidase is part of the polymorphonuclear leukocyte host defense system and myeloperoxidase is responsible for microbicide activity against a wide range of organisms. In stimulated PMN (polymorphonuclear leukocytes), MPO catalyzes the production of hypohalous acids, mainly hypochlorous acid in physiological situations and other toxic intermediates that significantly improve the microbicide activity of PMN.
Sensitivity
Sensitivity of dosage: 26 pg/ml.
Measurement range
Dose range: 156-1000 pg/ml.
Duration of dosing
Total duration of dosing: 3 h 10 min.
Reproducibility
Coefficient of variation intra-dose 6.2%, inter-dose 9.5%.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 15501547 |
| Specifications |
| Accession number | P05164 |
| Dose range | 156-10.000 pg/ml |
| Sensitivity of the dosage | 26 pg/ml |
| Conjugate | Biotin |
| Product type | Kit ELISA |
| Type of sample | Serum, Surnatant, Supernatant |
| Target species | Human |
| For use with (application) | ELISA |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | 4353 |
| Gene symbol(s) | MPO |
| Coefficient of inter-dose variation | 9.5% |
| Coefficient of intra-dose variation | 6.2% |
| Contents of kits | 96-well pre-coated microplate, Biotinylated detection antibody, Sample diluent, Sample diluent, lyophilized, Wash buffer concentrate, Wash buffer concentrate, Stop solution, 10x lysis pad, Adhesive plate covers, Adhesive plate covers |
| Marker or dye | HRP |
| Quantity | 128 Tests |
| Regulatory status | RUO |
| Synonym | Myeloperoxidase |
| Target | Human |
| Test time | 20 min |
| Physical characteristics |
| Volume of sample | Plasma, 10 μl; serum, 10 μl; supernatant, 10 μl |
| Storage and shipping |
| Storage conditions | -20°C |
| Total duration of dosing | 3 h 10 min |
Origin and customs
| Manufacturer ref. | BMS2038INST |
|---|
| Country of origin | Autriche |
|---|
| HS customs code | 3002 15 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.